Dr. Martin Madaus, the former CEO of Millipore, is stepping away from Covidien’s board to become the CEO of an unnamed company. Covidien (NYSE:COV) said Dr. Martin Madaus will step down from its board of directors to take an open CEO position with a privately-owned company. Madaus was North America president and CEO for Roche (PINK:RHHBY) and chairman & CEO of Millipore before it was bought out in 2010 by Merck KGaA.
Help employers find you! Check out all the jobs and post your resume.
